Filter
1363
Filtered Results: 1363
Text search:
biological
agents
Featured
Recommendations
144
New Publications
317
Language
Document type
No document type
714
Guidelines
250
Studies & Reports
219
Manuals
94
Strategic & Response Plan
36
Training Material
20
Fact sheets
17
Brochures
3
Situation Updates
3
Resource Platforms
2
Infographics
2
Online Courses
2
Dashboards/Maps
1
Countries / Regions
India
81
Global
63
Kenya
39
Nigeria
31
Sierra Leone
29
Ethiopia
26
South Africa
25
Africa
24
Western and Central Europe
21
Liberia
21
Latin America and the Carribbean
19
Tanzania
19
Uganda
19
Nepal
16
Bangladesh
14
Ghana
13
Philippines
13
Rwanda
11
Syria
11
Zambia
11
Zimbabwe
10
Congo, Democratic Republic of
10
Malawi
9
USA
9
South–East Asia Region
9
West and Central Africa
8
Eastern Europe
8
Brazil
8
Namibia
8
Ukraine
7
Mozambique
7
Cambodia
7
Germany
7
Lesotho
6
Guinea
6
Myanmar / Burma
6
Albania
5
Burkina Faso
5
Tajikistan
4
East and Southern Africa
4
South Sudan
4
Timor Leste/ East Timor
3
Senegal
3
Haiti
3
Eastern Europe and Central Asia
3
Paraguay
3
Spain
3
Vietnam
3
Mali
3
Angola
3
Eswatini/ Swaziland
3
Thailand
2
China
2
Peru
2
Guinea-Bissau
2
Venezuela
2
Lebanon
2
Sri Lanka
2
Libya
2
Botswana
2
Indonesia
2
Iraq
2
Pakistan
2
North Macedonia
1
El Salvador
1
Turkey
1
Cameroon
1
Iran
1
Singapore
1
Laos
1
Estonia
1
Niger
1
Mongolia
1
Asia
1
Dominican Republic
1
Middle East and North Africa
1
Western Pacific Region
1
Turkmenistan
1
Denmark
1
France
1
United Kingdom
1
Portugal
1
Latvia
1
Côte d’Ivoire / Ivory Coast
1
Belize
1
Costa Rica
1
Panama
1
Argentina
1
Papua New Guinea
1
Nicaragua
1
Moldova
1
Russia
1
Romania
1
Palestine
1
Honduras
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Countries
429
Clinical Guidelines
140
Key Resources
93
Public Health
85
Pharmacy & Technologies
50
Women & Child Health
40
Capacity Building
23
Toolboxes
Planetary Health
93
Rapid Response
85
COVID-19
83
Mental Health
78
TB
73
HIV
70
AMR
69
NTDs
66
Ebola & Marburg
56
Pharmacy
54
Specific Hazards
43
Conflict
26
Caregiver
25
NCDs
25
Malaria
21
Global Health Education
21
Natural Hazards
16
Refugee
14
Zika
14
Disability
11
Cholera
7
Polio
7
Social Ethics
4
Health Financing Toolbox
3
South Sudan
1
South Africa has faced many challenges over the past two decades, accomplishing profound positive changes in the social structure and government of the nation. This has not yet fully translated into better health for the population, however, particularly the poorest segment. In fact, the p...
Historically, the discovery of the sulfa drugs in the 1930s and the subsequent development of penicillin during World War II ushered in a new era in the treatment of infectious diseases. Infections that were common causes of death and disease in the pre-...
• provide scientific information on the safety, efficacy, and quality control/ quality assurance of widely used medicinal plants, in order to facilitate their appropriate use in Member States;
• provide models to assist Member States in developing their own mono- graphs or formularies for these...
The Sendai Framework for Disaster Risk Reduction 2015-2030 outlines seven clear targets and four priorities for action to prevent new and reduce existing disaster risks: (i) Understanding disaster risk; (ii) Strengthening disaster risk governance to manage disaster risk; (iii) Investing in disaster ...
In 2007, WHO warned that infectious diseases are emerging and re-emerging at a rate that has not been seen before. The potential for infectious diseases to spread rapidly results in high morbidity and mortality, causing a potential global public health treat of major concern.
Several factors are ...
Chromoblastomycosis (CMB) is a chronic fungal infection of the skin and the subcutaneous tissue caused by a transcutaneous traumatic inoculation of a specific group of dematiaceous fungi occurring mainly in tropical and subtropical zones worldwide. If not diagnosed at early stages, patients with CBM...
The Global Strategy for Tuberculosis Research and Innovation will support the efforts of governments and other stakeholders to accelerate TB research and innovation, and improve equitable access to the benefits of research.
Availabl in Arabic, Chinese, English, French, Spanish and Russian
Orientations provisoires
6 avril 2020
Le présent document résume les recommandations de l’OMS sur l’utilisation rationnelle de l’équipement de protection individuelle (EPI) dans les établissements de santé et lors des soins à domicile, ainsi que lors de la manipulation des cargaison...
WHO/CDS/TB/99.272
WHO’s Essential Medicines List and List of Essential Diagnostics are core guidance documents that help countries prioritize critical health products that should be widely available and affordable throughout health systems. The updated Essential Medicines List adds 23 medicines for children.
This update of the Guidelines for poison control, entitled Guidelines for establishing a poison centre, reflects the development of the role of poison centres in public health and the sound management of chemicals, described in section 1, and the opportunities provided by new technology. Assessments...
Este documento ha sido revisado y aprobado por la Ponencia de Alertas y Planes de Preparación y Respuesta. Este protocolo está en revisión permanente en función de la evolución y nueva información que se disponga de la infección por el nuevo coronavirus (SARS-CoV-2 ) .
